Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products ...

Enhanced Genomics has announced the appointment of Dr Katerina Leftheris to its Board of Directors.

Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022 ...

Eli Lilly has announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, a biopharmaceutical ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned ...

Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product ...

Amgen has announced a deal with the US government that will lower the company’s prescription drug costs for US patients while ...